Denmark

Loading...

DKK overview

PairLatest rateToday's change1 year change
DKKGBP0.1155
GBP
-0.00003 / -0.03%0.0026 / 2.27%
Today
0.1127Jun 09 20250.1187Nov 14 2025
DKKEUR0.1338
EUR
-0.00003 / -0.03%-0.0003 / -0.23%
Today
0.1333Mar 23 20260.1348Jun 23 2025
DKKUSD0.1541
USD
-0.00005 / -0.03%0.0013 / 0.85%
Today
0.1524Jun 10 20250.1618Jan 27 2026
DKKJPY24.71
JPY
-0.0057 / -0.02%2.58 / 11.63%
Today
22.05Jun 09 202525.15Apr 17 2026
DKKAUD0.2187
AUD
-0.00008 / -0.04%-0.0167 / -7.08%
Today
0.2155May 13 20260.2433Aug 21 2025
DKKCAD0.2148
CAD
0.00 / 0.00%0.0056 / 2.68%
Today
0.2089Mar 09 20260.2205Oct 17 2025
DKKCNY1.04
CNY
0.0001 / 0.01%-0.0553 / -5.04%
Today
1.05Jun 05 20261.04Jun 05 2026
DKKCHF0.1227
CHF
-0.00002 / -0.02%-0.0028 / -2.23%
Today
0.1202Mar 09 20260.1266Aug 18 2025

Equity fund country flows

This chart shows the cumulative weekly equity in country flows into or out of Denmark in USD. EPFR Global provides global coverage of foreign investor flows, tracking over 15,000 funds domiciled around the world.
As of May 19 2021.

Market movers

Constituents of the OMX Copenhagen 20 with the highest percent gain over one day.
ListingLastChangeVolume
Zealand Pharma A/SZEAL:CPH326.30
DKK
+27.00
+9.02%
1.01m
AP Moeller - Maersk A/SMAERSK B:CPH17,815.00
DKK
+1,360.00
+8.26%
32.26k
AP Moeller - Maersk A/SMAERSK A:CPH17,340.00
DKK
+1,310.00
+8.17%
9.33k
Novo Nordisk A/SNOVO B:CPH283.85
DKK
+12.05
+4.43%
7.44m
Genmab A/SGMAB:CPH1,583.50
DKK
+59.50
+3.90%
161.55k
FLSmidth & Co A/SFLS:CPH530.50
DKK
+16.50
+3.21%
136.04k
Demant A/SDEMANT:CPH252.20
DKK
+3.80
+1.53%
324.36k
Coloplast A/SCOLO B:CPH383.70
DKK
+4.60
+1.21%
454.81k
DSV A/SDSV:CPH1,611.50
DKK
+16.00
+1.00%
304.33k
Rockwool A/SROCK B:CPH199.30
DKK
+1.40
+0.71%
595.41k
Data delayed at least 15 minutes, as of Jun 04 2026 15:59 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.